EXAGEN INC. Annual Operating Income (Loss) in USD from 2018 to 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Exagen Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2023.
- Exagen Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$4.66M, a 8.01% increase year-over-year.
- Exagen Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$15.4M, a 52.1% increase year-over-year.
- Exagen Inc. annual Operating Income (Loss) for 2023 was -$22.8M, a 50.4% increase from 2022.
- Exagen Inc. annual Operating Income (Loss) for 2022 was -$46.1M, a 91.3% decline from 2021.
- Exagen Inc. annual Operating Income (Loss) for 2021 was -$24.1M, a 58.5% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)